What should be the entry pain intensity criteria for chronic pain clinical trials? An IMMPACT update-Reference-Cited by-同舟云学术

What should be the entry pain intensity criteria for chronic pain clinical trials? An IMMPACT update

Published:2023-06-07 Issue:9 Volume:164 Page:1927-1930
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:PAIN

Author:

Langford Dale J.¹²³,Baron Ralf⁴,Edwards Robert R.⁵,Gewandter Jennifer S.²,Gilron Ian⁶,Griffin Robert¹,Kamerman Peter R.⁷,Katz Nathaniel P.⁸,McDermott Michael P.²,Rice Andrew S.C.⁹,Turk Dennis C.³,Vollert Jan⁹,Dworkin Robert H.²

Affiliation:

1. Department of Anesthesiology, Critical Care, and Pain Management, Hospital for Special Surgery, New York, NY, United States

2. Department of Anesthesiology and Perioperative Medicine, University of Rochester, Rochester, NY, United States

3. Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, United States

4. Department of Neurology, University of Kiel, Kiel, Germany

5. Department of Anesthesiology, Perioperative and Pain Medicine, Harvard Medical School, Boston, MA, United States

6. Department of Anesthesiology and Perioperative Medicine, Queen's University, Kingston, ON, United States

7. School of Psychology, University of the Witwatersrand, Johannesburg, South Africa

8. Department of Anesthesiology, Tufts University, Boston, MA, United States

9. Department of Surgery and Cancer, Imperial College London, London, United Kingdom

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),Neurology

Reference28 articles.

1. An investigation of factors contributing to higher levels of placebo response in clinical trials in neuropathic pain: a systematic review and meta-analysis;Arakawa;Clin Drug Investig,2015

2. Regression to the mean: what it is and how to deal with it;Barnett;Int J Epidemiol,2004

3. Spinal cord stimulation for the management of painful diabetic neuropathy: a systematic review and meta-analysis of individual patient and aggregate data;Duarte;PAIN,2021

4. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations;Dworkin;PAIN,2010

5. Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations;Dworkin;PAIN,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topical amitriptyline in burning mouth syndrome: A retrospective real‐world evidence study;Headache: The Journal of Head and Face Pain;2024-08-23

2. Comment on ‘A sham‐controlled, randomized trial of spinal cord stimulation for the treatment of pain in chronic pancreatitis’ by Gulisano et al.;European Journal of Pain;2024-08-19

3. Mean of Daily Versus Single Week Recall-Based Pain Quality Assessments in Neuropathic Pain Trials: Implications for Assay Sensitivity;The Journal of Pain;2024-07

4. Effect of esketamine combined with pregabalin on acute postsurgical pain in patients who underwent resection of spinal neoplasms: a randomized controlled trial;Pain;2024-03-15

5. On the importance of baseline pain intensity and measurement methods;Pain;2023-05-05